Workflow
ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group
Globenewswire· 2025-10-22 11:30
Appointment reinforces ProMIS Neurosciences’ strategic vision and deepens investor engagement as the Company advances its differentiated Alzheimer’s program, PMN310 Cambridge, Massachusetts, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced that Slanix Paul Alex, Pharm.D., President and Portfolio Manager for Ally Bridge Grou ...
POET Technologies Receives $5 Million Production Order for 800G Optical Engines
Globenewswire· 2025-10-22 11:29
Core Insights - POET Technologies Inc. has received a production order exceeding US$5 million for its POET Infinity™ optical engines, intended for AI data servers [1][2][3] - The order signifies the commercial viability and scalability of POET's technology, which is designed to support AI connectivity and meet the demands of hyperscale data centers [2][5] - The optical engines are scheduled for delivery in the second half of 2026, with specific configurations including 400G transmit and 800G receive engines [3][4] Company Overview - POET Technologies specializes in high-speed optical modules, optical engines, and light source products for the AI systems market and hyperscale data centers [6] - The company's technology is based on the POET Optical Interposer™, which integrates electronic and photonic devices into a single chip, offering lower costs, reduced power consumption, and smaller sizes compared to traditional products [6] - POET's products are scalable for high production volumes and address challenges in various applications, including AI clusters, 5G networks, and autonomous vehicle systems [6] Market Outlook - The market for optical transceivers and related products is projected to double from US$5 billion in 2024 to US$10 billion by 2026, driven by the growth of AI clusters [5]
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
Globenewswire· 2025-10-22 11:20
SAN FRANCISCO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines in oncology and autoimmune disease, today announced the pricing of its underwritten registered offering of 24,485,799 shares of its common stock at a price of $10.21 per share. The gross proceeds to Nurix from the offering, before deducting underwriting discounts and commissio ...
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
Globenewswire· 2025-10-22 11:20
Highlights Government-Funded Pipeline and Expanding Role of Public-Private Partnerships in Biodefense InnovationHALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) (“Appili” or the “Company”) today announced that it will attend the Biomedical Advanced Research and Development Authority (BARDA) Innovation Symposium on November 20, 2025, in Washington, D.C. The event brings together leaders from government, industry, and academia to advance the develop ...
Gilat to Report Third Quarter 2025 Results on Wednesday, November 12th
Globenewswire· 2025-10-22 11:18
PETAH TIKVA, Israel, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it will release its third quarter 2025 financial results on Wednesday, November 12, 2025. Conference Call and WebcastFollowing the release, Adi Sfadia, Chief Executive Officer, and Gil Benyamini, Chief Financial Officer, will discuss Gilat’s third quarter 2025 results and business achievements and ...
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Globenewswire· 2025-10-22 11:00
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million. Biossil assumes all further obligations to Blackstone Life Sciences under the 2018 Amended and Restated Purchase and Sale Agreement (the Ro ...
Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025
Globenewswire· 2025-10-22 11:00
BOSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a virtual key opinion leader (KOL) event on Thursday, November 13, 2025 at 10:00 AM ET to discuss a wide range of hepatitis C virus (HCV)-related topics including the current HCV patient population, the importance of early diagnosis ...
Old National Bancorp Reports Third Quarter 2025 Results
Globenewswire· 2025-10-22 11:00
EVANSVILLE, Ind., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Old National Bancorp (NASDAQ: ONB) reports 3Q25 net income applicable to common shares of $178.5 million, diluted EPS of $0.46; $231.3 million and $0.59 on an adjusted1 basis, respectively. CEO COMMENTARY: "Old National's outstanding quarterly results reflect our continued focus on the fundamentals and the benefits from our recent partnership with Bremer Bank," said Chairman and CEO Jim Ryan. "Furthermore, with conversion activities related to our Bremer ...
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
Globenewswire· 2025-10-22 11:00
Core Insights - Village Farms International, Inc. has launched an innovative one-way aroma valve in its Pure Sunfarms brand packaging, allowing consumers to smell the cannabis flower before purchase, marking a first in Canada [1][2][3] Company Overview - Village Farms is a large-scale, vertically-integrated supplier of plant-based Consumer Packaged Goods, leveraging decades of experience in Controlled Environment Agriculture [5] - The company operates one of the largest cannabis operations globally, with 2.2 million square feet of greenhouse production in Canada, and is recognized as a low-cost producer with high-quality products [6] Product Innovation - The one-way aroma valve is pressure-activated, enabling the release of the flower's scent when squeezed, while preventing air and contaminants from entering the package, enhancing the consumer experience [2][3] - This innovation follows the introduction of window packaging, furthering the mission to make cannabis shopping more accessible and informative [3][4] Market Expansion - Village Farms is targeting international cannabis opportunities, exporting medical cannabis to markets such as Germany, the UK, Israel, Australia, and New Zealand, and expanding its export business [7] - The company plans to enter the US THC market, utilizing its Texas-based greenhouse assets for future growth [8]
Marex Group plc to acquire European fixed income market maker Valcourt SA
Globenewswire· 2025-10-22 11:00
LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces that it has agreed to acquire Valcourt SA (“Valcourt”). Valcourt is a fixed income market maker based in Geneva, Switzerland, specialising in fixed income instruments such as high-yield, subordinated, emerging markets, private, illiquid, and sustainable debt. The acquisition will add 700 clients ranging from banks, independent wealth managers an ...